Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2011; 17(34): 3899-3911
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3899
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3899
Enzyme | DMSO | BSO | AZA | BSO/AZA |
AST (IU/L) | 91.07 ± 8.36 | 62.79 ± 3.89 | 124.90 ± 10.56 | 154.30 ± 19.75a |
ALT (IU/L) | 31.50 ± 9.12 | 22.36 ± 2.85 | 36.17 ± 5.44 | 42.29 ± 9.04 |
CK (IU/L) | 598.60 ± 112.10 | 416.00 ± 89.28 | 904.40 ± 129.40 | 918.50 ± 128.70 |
- Citation: Hernández-Breijo B, Monserrat J, Ramírez-Rubio S, Cuevas EP, Vara D, Díaz-Laviada I, Fernández-Moreno MD, Román ID, Gisbert JP, Guijarro LG. Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World J Gastroenterol 2011; 17(34): 3899-3911
- URL: https://www.wjgnet.com/1007-9327/full/v17/i34/3899.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i34.3899